MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,545 | -18.7% | 175 | 0.0% | 0.00% | – |
Q2 2023 | $3,131 | -23.0% | 175 | 0.0% | 0.00% | – |
Q1 2023 | $4,066 | -73.6% | 175 | -83.5% | 0.00% | -100.0% |
Q4 2022 | $15,381 | -23.1% | 1,060 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $20,000 | +5.3% | 1,060 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $19,000 | -29.6% | 1,060 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $27,000 | -97.8% | 1,060 | -98.8% | 0.00% | -98.9% |
Q1 2020 | $1,255,000 | -35.8% | 87,727 | +22.1% | 0.19% | -10.0% |
Q4 2019 | $1,956,000 | +4.3% | 71,837 | +9.6% | 0.21% | -9.9% |
Q3 2019 | $1,876,000 | +6.5% | 65,537 | +3.3% | 0.23% | +8.4% |
Q2 2019 | $1,762,000 | -17.0% | 63,442 | -0.8% | 0.22% | -21.5% |
Q1 2019 | $2,124,000 | +19.7% | 63,985 | +4.8% | 0.27% | +2.6% |
Q4 2018 | $1,775,000 | -34.4% | 61,070 | +3.9% | 0.27% | -26.0% |
Q3 2018 | $2,704,000 | +35.8% | 58,781 | +10.3% | 0.36% | +28.9% |
Q2 2018 | $1,991,000 | +32.1% | 53,290 | +4.5% | 0.28% | +30.8% |
Q1 2018 | $1,507,000 | -12.4% | 50,985 | +1.7% | 0.21% | -12.7% |
Q4 2017 | $1,721,000 | -2.3% | 50,120 | +2.9% | 0.24% | -8.2% |
Q3 2017 | $1,762,000 | +55.5% | 48,710 | +11.1% | 0.27% | +48.3% |
Q2 2017 | $1,133,000 | +74.3% | 43,857 | +29.6% | 0.18% | +60.7% |
Q1 2017 | $650,000 | +57.0% | 33,847 | +36.4% | 0.11% | +45.5% |
Q4 2016 | $414,000 | -7.2% | 24,822 | +14.5% | 0.08% | -15.4% |
Q3 2016 | $446,000 | -30.2% | 21,684 | +3.9% | 0.09% | -34.1% |
Q2 2016 | $639,000 | -15.7% | 20,874 | +3.1% | 0.14% | -19.8% |
Q1 2016 | $758,000 | +1.1% | 20,254 | +16.6% | 0.17% | -5.0% |
Q4 2015 | $750,000 | +32.3% | 17,369 | +14.8% | 0.18% | +24.0% |
Q3 2015 | $567,000 | +23.8% | 15,124 | +11.8% | 0.15% | +29.2% |
Q2 2015 | $458,000 | -11.1% | 13,524 | -7.0% | 0.11% | -16.3% |
Q1 2015 | $515,000 | +14.4% | 14,540 | +9.9% | 0.14% | +8.9% |
Q4 2014 | $450,000 | -9.3% | 13,225 | +2.9% | 0.12% | -15.1% |
Q3 2014 | $496,000 | +2.9% | 12,855 | +3.7% | 0.15% | +2.8% |
Q2 2014 | $482,000 | +13.7% | 12,395 | 0.0% | 0.14% | +5.2% |
Q1 2014 | $424,000 | +58.8% | 12,395 | -2.7% | 0.14% | +53.4% |
Q4 2013 | $267,000 | -10.4% | 12,735 | +0.3% | 0.09% | -18.5% |
Q3 2013 | $298,000 | -12.6% | 12,700 | 0.0% | 0.11% | -20.6% |
Q2 2013 | $341,000 | – | 12,700 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |